CCI
23
-2
CHRW
51
-6
NSC
37
-3
MAS
52
-2
KEY
31
2
PNC
53
-2
CA
25
-7
RSG
62
-2
CMS
57
3
MCO
74
-3
NKE
37
-3
LYB
25
-14
EXR
48
-3
FOX
68
-2
GOOG
81
-2
UHS
52
2
TROW
50
2
KO
44
-2
MCHP
43
6
NFLX
74
-2
CCI
23
-2
CHRW
51
-6
NSC
37
-3
MAS
52
-2
KEY
31
2
PNC
53
-2
CA
25
-7
RSG
62
-2
CMS
57
3
MCO
74
-3
NKE
37
-3
LYB
25
-14
EXR
48
-3
FOX
68
-2
GOOG
81
-2
UHS
52
2
TROW
50
2
KO
44
-2
MCHP
43
6
NFLX
74
-2
Financhill
Back

Ginkgo Bioworks Holdings 10K Form

Sell
45

DNA
Ginkgo Bioworks Holdings

Last Price:
9.44
Seasonality Move:
-37.29%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive DNA News And Ratings

See the #1 stock for the next 7 days that we like better than DNA

DNA Financial Statistics

Sales & Book Value

Annual Sales: $251.46M
Cash Flow: $-118.59M
Price / Cash Flow: 0
Annual Sales: $15.03
Price / Book: 0.68

Profitability

EPS (TTM): -12.99000
Net Income (TTM): $-651.19M
Gross Margin: $197.45M
Return on Equity: -65.54%
Return on Assets: -38.86%

Ginkgo Bioworks Holdings Earnings Forecast

Key Ginkgo Bioworks Holdings Financial Ratios

  • The Gross Profit Margin over the past 5 years for DNA is 78.52%.
  • The Selling, General & Administrative Expenses for DNA have been equal to 153.12% of Gross Profit Margin.
  • The Research & Development expenses have been 230.90% of Revenue.
  • The Interest Expense is -0.01% of Operating Income.
  • The Net Earning history of DNA is -355.08% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 2 years.

Ginkgo Bioworks Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Chemicals
Sector: Materials
Current Symbol: DNA
Website: ginkgobioworks.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.79
Quick Ratio: 5.59

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

DNA Technical Analysis vs Fundamental Analysis

Sell
45
Ginkgo Bioworks Holdings (DNA) is a Sell

Is Ginkgo Bioworks Holdings a Buy or a Sell?